Detailed View
ABCL - AbCellera Biologics Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
1,645,973,376
Adj EBIT (TTM)
-211,962,000
Enterprise Value
1,610,223,376
Last Price
5.39
Earnings Yield
-13.16%
Return on Capital
-18.05%
Capital
1,174,552,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 8,315,000 | -57,519,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 44,854,000 | -28,580,000 |
| 2025-09-30 | 10-Q | 2025 | 8,955,000 | -76,278,000 |
| 2025-06-30 | 10-Q | 2025 | 17,084,000 | -49,585,000 |
| 2025-03-31 | 10-Q | 2025 | 4,235,000 | -62,660,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 5,049,000 | -72,755,000 |
| 2024-09-30 | 10-Q | 2024 | 6,507,000 | -93,663,000 |
| 2024-06-30 | 10-Q | 2024 | 7,323,000 | -93,454,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.